2013
DOI: 10.1172/jci70212
|View full text |Cite
|
Sign up to set email alerts
|

Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer

Abstract: Four decades ago, angiogenesis was recognized as a therapeutic target for blocking cancer growth. Because of its importance, VEGF has been at the center stage of antiangiogenic therapy. Now, several years after FDA approval of an anti-VEGF antibody as the first antiangiogenic agent, many patients with cancer and ocular neovascularization have benefited from VEGF-targeted therapy; however, this anticancer strategy is challenged by insufficient efficacy, intrinsic refractoriness, and resistance. Here, we examine… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
461
0
14

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 543 publications
(477 citation statements)
references
References 164 publications
(167 reference statements)
2
461
0
14
Order By: Relevance
“…Development of functional and mature blood vessel networks in implantable engineered tissues is fundamental to effective application of tissue engineering techniques toward treatment of a diversity of diseases, such as ischemia and cancer (29,30). Therefore, much contemporary research focuses on exploring the molecular determinants of the vasculogenesis and angiogenesis processes (31)(32)(33).…”
Section: Discussionmentioning
confidence: 99%
“…Development of functional and mature blood vessel networks in implantable engineered tissues is fundamental to effective application of tissue engineering techniques toward treatment of a diversity of diseases, such as ischemia and cancer (29,30). Therefore, much contemporary research focuses on exploring the molecular determinants of the vasculogenesis and angiogenesis processes (31)(32)(33).…”
Section: Discussionmentioning
confidence: 99%
“…However, this vasculature was not stable and degraded faster when compared to the oscillatory stretched constructs (Figures 1C and 3C). In contrast, the higher levels of vessel‐initiating cytokines at later time points and the stabilizing cytokines such as angiopoitin1, which activates mural cells to attach to the forming vessels and which has an important role in maintaining vessel quiescence,17 indicate that these vessels reach higher maturation levels and thus are stable over longer time periods ( Figure 4 ). …”
Section: Resultsmentioning
confidence: 99%
“…As mural cell characteristics have been shown to have a major impact on vessel stabilization,17 we then examined mural cell differentiation within oscillatory stretched constructs. αSMA and PDGFR‐β are markers for fibroblasts differentiation into myo‐fibroblasts, and are indicators for vessel maturation 18.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…This multistage process is essential for cancer progression above 2-3 mm 3 [27]. Furthermore, the invasiveness of cancer depends on forming new vessels inside the tumor [28]. The proangiogenic effect of the main angiogenesis stimulating factor -VEGF results from VEGFR-2 activation, whereas the role of VEGFR-1 is not fully recognized yet [9,10,12].…”
Section: Discussionmentioning
confidence: 99%